Rollins Inc.
ROL
$53.02
-0.47%
Rollins, Inc. is a global leader in route-based pest and termite control services, operating primarily under its flagship Orkin brand across North America and several other international markets. The company is a dominant player in the essential but fragmented pest control industry, leveraging its extensive service network, brand recognition, and recurring residential and commercial contracts to maintain a competitive edge. The current investor narrative centers on the stock's defensive characteristics and steady cash generation being weighed against a recent period of significant underperformance relative to the broader market, raising questions about growth sustainability and valuation in a higher interest rate environment.…
ROL
Rollins Inc.
$53.02
Investment Opinion: Should I buy ROL Today?
Hold. The core thesis is that Rollins is a high-quality, cash-generative business currently priced for perfection, making it vulnerable to further multiple compression unless growth re-accelerates.
Supporting this view, the stock trades at a demanding 55.2x trailing P/E and 38.3x forward P/E, implying significant earnings growth expectations that recent quarterly margin volatility (Q4 net margin of 12.8% vs. Q3's 15.9%) calls into question. While revenue growth remains positive at 9.7% YoY and free cash flow generation is robust at $650 million TTM, the stock's severe technical underperformance (-30.42 points of relative strength vs. the S&P 500 over one year) reflects deep investor skepticism about sustaining these valuation levels.
The rating would upgrade to Buy if the forward P/E compresses below 30x while revenue growth stabilizes above 8% and net margins recover to above 14%. It would downgrade to Sell if revenue growth decelerates below 5% or if the stock breaks below its 52-week low on high volume. Relative to its own rich history and the defensive services sector, the stock is overvalued, as the current price embeds expectations of a swift operational recovery that is not yet evident in the most recent quarterly data.
Sign up to view all
ROL 12-Month Price Forecast
The outlook is neutral with a downward bias. The company's underlying business is sound, generating strong cash flows from a defensive service model. However, the stock's extreme valuation (55.2x trailing P/E) has collided with operational stumbles (Q4 margin compression), resulting in severe underperformance. The base case is a period of consolidation and multiple compression as the company works to stabilize profitability. The stance would upgrade to bullish on evidence of sustained margin recovery above 15% or a material drop in the forward P/E below 30x. It would turn bearish on a breakdown below the $52 support level on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rollins Inc.'s 12-month outlook, with a consensus price target around $68.93 and implied upside of +30.0% versus the current price.
Average Target
$68.93
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$42 - $69
Analyst target range
Analyst coverage is limited with only 5 firms providing estimates, indicating this is a stock with more niche institutional interest. The consensus sentiment appears mixed, as evidenced by recent rating actions including a downgrade from Wells Fargo to 'Equal Weight' and an upgrade from Morgan Stanley to 'Overweight' in late 2025. Without a provided average target price, the implied upside or downside cannot be calculated, but the wide range in EPS estimates—from a low of $1.70 to a high of $1.80—points to a moderate level of uncertainty regarding near-term earnings power. The pattern of recent ratings shows a balance of holds and outperform calls, with no strong directional consensus, which aligns with the stock's challenging technical and fundamental backdrop.
Bulls vs Bears: ROL Investment Factors
The evidence currently leans bearish, driven by a punishing combination of extreme valuation and deteriorating technical momentum. The most compelling bull points—strong cash flow and a defensive business model—are being overshadowed by a market unwilling to pay a 55x P/E for decelerating growth and margin volatility. The single most important tension in the investment debate is whether the company's high-quality, cash-generative franchise can justify its premium valuation in a higher-rate environment that compresses multiples for all but the fastest growers. If growth re-accelerates and margins stabilize, the stock could rebound sharply from oversold levels; if not, the valuation multiple is likely to contract further.
Bullish
- Robust Cash Flow Generation: The company generated $650 million in TTM free cash flow, supporting a high ROE of 38.3%. This strong cash generation funds dividends, buybacks, and acquisitions, underpinning shareholder returns despite the price decline.
- Defensive Business Model: Pest control is an essential, recurring service, providing revenue stability. This is reflected in consistent, positive revenue growth, with the most recent quarter showing a 9.7% YoY increase to $912.9 million.
- High Profitability Margins: Rollins maintains strong profitability with a TTM net margin of 14.0% and an operating margin of 19.4%. These metrics demonstrate the company's pricing power and operational efficiency in its core markets.
- Technically Oversold Condition: The stock is trading just 10.4% above its 52-week low of $51.95, following a -20.03% maximum drawdown and severe underperformance vs. the S&P 500 (-30.42 pts over 1 year). This suggests potential for a technical rebound if sentiment improves.
Bearish
- Extremely High Valuation Multiples: The stock trades at a trailing P/E of 55.2x and a forward P/E of 38.3x, which are exceptionally high for a defensive service business. The EV/EBITDA of 35.5x and P/S of 7.7x leave no margin for error.
- Significant Margin Compression: Q4 2025 net margin declined to 12.8% from 15.9% in Q3 2025, and gross margin fell to 47.5% from 54.4% the prior quarter. This volatility raises concerns about cost control and pricing power.
- Severe Price and Relative Weakness: The stock is down 5.23% over the past year while the S&P 500 gained 25.19%, a 30.42-point deficit. Momentum remains negative, with the stock down 7.99% over the past three months, indicating persistent selling pressure.
- Elevated Short Interest & Low Liquidity: A short ratio of 3.09 indicates significant bearish sentiment. Furthermore, the current ratio of 0.60 suggests low liquidity, which could amplify volatility and limit financial flexibility in a downturn.
ROL Technical Analysis
The stock is in a pronounced downtrend, having declined 5.23% over the past year, which starkly contrasts with the S&P 500's 25.19% gain, resulting in a severe relative strength deficit of -30.42 points. Currently trading at $53.42, the price sits just 10.4% above its 52-week low of $51.95, positioning it in the lower quintile of its annual range and signaling potential oversold conditions or fundamental distress. Recent momentum remains negative, with the stock down 1.77% over the past month and 7.99% over the past three months, indicating the selling pressure has persisted and accelerated from the longer-term trend. The stock's beta of 0.79 suggests it has been 21% less volatile than the market, which ironically did not protect it from deep losses during this period. Key technical support is clearly defined at the 52-week low near $51.95, while resistance has formed around the recent highs near $66.14; a sustained break below support could trigger another leg down, whereas a recovery above the $60 level might signal a stabilization attempt. The stock's maximum drawdown of -20.03% and elevated short ratio of 3.09 further underscore the bearish sentiment and elevated risk of continued volatility.
Beta
0.79
0.79x market volatility
Max Drawdown
-20.0%
Largest decline past year
52-Week Range
$52-$66
Price range past year
Annual Return
-7.0%
Cumulative gain past year
| Period | ROL Return | S&P 500 |
|---|---|---|
| 1m | -3.1% | +5.5% |
| 3m | -13.6% | +7.7% |
| 6m | -12.1% | +12.7% |
| 1y | -7.0% | +27.4% |
| ytd | -10.2% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ROL Fundamental Analysis
Revenue growth remains positive but has shown signs of deceleration; the most recent quarterly revenue was $912.9 million, representing a 9.7% year-over-year increase, though this is down from the stronger growth seen in prior quarters of 2025. Segment data from the latest quarter shows Residential Contract Revenue of $405.0 million slightly outpacing Commercial Contract Revenue of $304.9 million, indicating the core residential market continues to be the primary growth driver. The company is solidly profitable, with net income of $116.4 million in Q4 2025 and a trailing twelve-month net margin of 14.0%, supported by a gross margin of 49.4% and an operating margin of 19.4%. However, profitability metrics have fluctuated quarterly, with the Q4 2025 net margin of 12.8% being lower than the Q3 2025 margin of 15.9%, suggesting some margin compression in the most recent period. The balance sheet is moderately leveraged with a debt-to-equity ratio of 0.97, but the company generates robust cash flow, evidenced by free cash flow of $650.0 million on a TTM basis and an ROE of 38.3%, indicating efficient use of equity capital. The current ratio of 0.60 points to relatively low liquidity, which is typical for asset-light service businesses, but the strong and consistent free cash flow generation provides ample internal funding for dividends, share buybacks, and acquisitions.
Quarterly Revenue
$912913000.0B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$650021000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ROL Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 55.2x, which is significantly higher than the forward PE of 38.3x, indicating the market expects a substantial rebound in earnings over the next twelve months. Compared to its own historical range, the current trailing PE of 55.2x is below the peak levels seen in late 2025 (62.2x in Q4) but remains elevated relative to its multi-year average, suggesting the stock is not at a deep historical discount despite the price decline. The Price-to-Sales ratio of 7.7x and EV/EBITDA of 35.5x are also rich multiples that demand high growth and margin stability, leaving little room for operational missteps in the current macroeconomic climate.
PE
55.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 36x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is valuation compression, given the stock's rich multiples (55.2x trailing P/E, 35.5x EV/EBITDA) which demand flawless execution. Recent quarterly margin volatility is a red flag, with the net margin dropping 310 basis points from Q3 to Q4 2025. While the debt-to-equity ratio of 0.97 is manageable, the low current ratio of 0.60 indicates limited short-term liquidity, though this is mitigated by strong annual free cash flow of $650 million.
Market & Competitive Risks: The stock faces significant market risk as a high-multiple, slower-growth name in a rising rate environment, evidenced by its severe underperformance (beta of 0.79 yet down 5.2% vs. market up 25.2%). Competitive risks in the fragmented pest control industry could pressure pricing, further squeezing the recently volatile gross margin (49.4% TTM). The stock's premium valuation (P/S of 7.7x) makes it vulnerable to sector rotation out of expensive defensive stocks if growth equities regain favor.
Worst-Case Scenario: The worst-case scenario involves a continuation of margin pressure combined with a growth scare, triggering a full derating from its current premium multiples. This could be catalyzed by a recession impacting residential contract renewals or a significant inflationary spike in labor and chemical costs. In this adverse scenario, the stock could re-test and break its 52-week low of $51.95, representing a downside of approximately -3% from the current $53.42. A more severe derating towards its historical valuation trough could see a drawdown exceeding the recent -20% maximum.
FAQ
The key risks are, in order of severity: 1) Valuation Risk: The extreme P/E of 55.2x makes the stock highly susceptible to multiple compression if growth disappoints. 2) Operational Risk: Recent margin volatility, with Q4 2025 net margin dropping to 12.8% from 15.9% in Q3, indicates potential cost or pricing pressures. 3) Market/Sentiment Risk: The stock has severe negative momentum, down 5.2% over the past year versus a +25.2% market, and bears have a elevated short interest (short ratio of 3.09). 4) Liquidity Risk: A current ratio of 0.60 is low, though mitigated by strong cash flow.
The 12-month outlook presents three scenarios. The Base Case (60% probability) sees the stock trading sideways in a $54-$60 range as high valuation caps upside despite stable fundamentals. The Bull Case (20% probability) projects a recovery to $66-$70 on successful margin improvement and a market flight to quality. The Bear Case (20% probability) foresees a derating to $48-$52 if margin pressure continues and growth slows. The base case is most likely, anchored by the current forward P/E of 38.3x and analyst EPS estimates clustering around $1.76. The key assumption is that revenue growth remains near 10% without further margin deterioration.
ROL stock is overvalued relative to its recent growth trajectory and margin profile. The primary metric, a trailing P/E of 55.2x and a forward P/E of 38.3x, is extremely high for a company in the essential services sector, especially one that just reported sequential margin compression. The Price-to-Sales ratio of 7.7x and EV/EBITDA of 35.5x are also rich. This valuation implies the market expects a significant acceleration in earnings growth and margin expansion, which recent quarterly results have not yet demonstrated. Compared to its own historical multiples and the sector, it trades at a substantial premium.
ROL is not a compelling buy at current levels for most investors. While the company has a strong, defensive business generating $650M in annual free cash flow, the stock is overvalued with a 55.2x trailing P/E and has shown significant technical weakness, underperforming the S&P 500 by over 30 points in the last year. It could be a good buy for a very patient, value-oriented investor only if the price falls significantly further (towards the $48-$52 range) to provide a larger margin of safety, or if upcoming quarterly reports show a decisive recovery in profitability margins.
ROL is unsuitable for short-term trading due to its negative momentum, high short interest, and lack of near-term catalysts. Its low beta of 0.79 suggests it should be less volatile, but it has significantly underperformed the market recently. The stock is better suited for a long-term (3-5 year) investment horizon, allowing time for its premium valuation to be absorbed by earnings growth and for its defensive, cash-generative business model to compound value. However, long-term investors should be prepared for potential further volatility and price declines before any sustained recovery. A minimum holding period of 2-3 years is suggested to weather the current valuation reset.